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Apocynin is a constituent of root extracts of the medicinal herb Picror/ti:o kttrroa and has been shown to possess anti-inflammatory properties. 
We investigated the etIxts of apocynin on the production of arachidonic acid-derived inflammatory mediators by guinea pig pulmonary macro- 
phages. Apocynin concentration-dependently i hibited the formation of thromboxane A_ ,, whereas the release of prostaglandins Ez and Fz, was 
stimulutLz. Apocynin potently inhibited arachidonic acid-induced aggregation of bovine platelets. possibly through inhibition of thromboxane 
formation. The present results uggest thot apocynin might, beside its therapeutic effects in inflammatory conditions when given in a root extract 
of P. kurroa, also be a valuable tool in the development of new anti-inflammatory or anti-thrombic drugs, 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Picroh’za kurroa is an Himalayan herb that has been 
extensively used in Oriental medicine for a variety of 
conditicns, including liver and lung diseases, fever, skin 
lesions, worm infections, rheumatic diseases, urinary 
disorders, heart failure and snake and scorpion bites. 
One of the active principles of the root extract of f? 
knrroa is apocynin (4-hydroxy-3-methoxyacetophe- 
none) [l] or its glycoside derivative, androsin [2]. 
Apocynin was proven to be effective in vivo. Orally 
administered apocynin protected WAG/Rij rats to au- 
toimmune-arthritis [3] and to ulcerative skin lesions in- 
duced with tubercle bacteria (submitted for publica- 
tion). In vitro experiments have shown dlat apocynin 
inhibits the generation of reactive oxygen species from 
human neutrophils [4], which might be responsible for 
the beneficial effects of P. kurroa in inflammatory con- 
ditions. In order to further explore the basis of the 
anti-inflammatory properties of apocynin, we have 
studied the effects of this drug on the formation of 
arachidonic acid-derived mediators, which are also of 
importance in tt;, a inflammztery process [5.63. Our data 
indicate that apo:ynin inhibits the formation of throm- 
boxanes (i’x), but stimulates th:: generation of prosta- 
glandins (PG) E2 and Fzn. The results also indicate that 
apocynin potently inhibits arachidonic acid-induced 
platelet aggregation, possibly through an inhibitory ef- 
feet on thromboxane formation. 
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2. I. lshtiott of gtrineu pig pttktottury trtucrophagcs 
Pulmonary macrophages (PM) were obtained from malt, specified 
pathogen free guinea pigs (Dunkin Hartley strain, 400-600 g, Harlan 
Olac Ltd., Bicester. UK) through lung lavagc in situ, as described 
previously [7]. Combined lavage fluids were centrifuged at 4OOxg for 
IO min at 4°C. The cells were subsequently washed twice and finally 
resuspended in Krebs-bicurbonnte solution of the followingcomposi- 
tion: 118.1 mM N&I, 4,7 mM KCI, 2,5 mM CaC1~.2Hz0, I.2 mM 
MgS0,.71_1(3, 25.0 mM NaHCO,, 1.2 mM KH:PO,. and 8.3 mM 
glucose (pH 7.4). The cell preparations thus obtained contained 52% 
neutrophils and IO-20% lymphocytes. Viability was 295% as judged 
by Trypan blue dye exclusion. PM were identified by morpholoW and 
diffuse staining for nonspecific sterasc. 
2,2. EI/i’u of upucytitt 011 rite generuriort of uruchirlonic ucirl tmw- 
bbfitm by pubrrortary rmcrophagcs 
PM (5x10’ cells/ml) were incubated for I5 min at 37°C in a shaking 
waler bath with different concentrations of apocynin. The cells were 
subsequently stimulated by addition of exogenous arachidonic acid 
(30,ttM) and phorbol myristate acetate (PMA, IO @ml). The incuba- 
tions were continued for another I5 min, after which the cells were 
sedimented by centrifugation at 4°C for 10 min at 1225xg. Part ofthe 
supernatants was stored at -20°C for the analysis of TxB, by specitic 
radioimmunoassay, which was carried out according to the manufac- 
turer’s instructions. The remaining part of the supernatants was sub- 
jccted to an initial extraction using disposable reverse phase C,, extrac- 
tion columns (J.T. Bnkcr, Devcnter, TheNetherlands). Prior to extrac- 
lion, the internal stnndurds PGE, at:d POB, were added to correct For 
extraction losses. The Cl” extracts were fractionated on Silica Gel 60 
columns according to the method of Claeys et al. [S], yielding fractions 
containing apolar products (A), monohydroxy acids (B), dihydroxy 
acids (C), and prosraglundins (D), respectively. Frirction B, containing 
12-hvdroxv-heutadccatrienoicacid IHHT). and Fraction D.contninin!z 
PGE? and PG’Fzg, were finally andlyzcd-by reverse phase HPLC ai 
dcscribcd previously [!I.lO]. 
2.3. Isvbrir~rt oJ’hovim p/ute/eIS 
Citreted bovine blood wets centrifuged at 24Oxg for 20 min at room 
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temperature. The upper phase was withdrawn and used as platelcl rich 
plasma (PRP). whereas the remaining Ruid was further centrifuged at 
1760%~ for IO min at room temperature. The upper phase was again 
collected and represented pkt~elet poor plasma (PPP). .4ll cxperimen- 
tal procedures were carried out using plastics to prevent spontaneous 
platelet aggregation. 
Platelet aggregation was measured ina Pnylon dual channel aggre. 
gometer. PRP and PPP were used to adjust 0% and 100% readings of 
the apparatus. respectively. PRP was incubated for IO min whh differ- 
ent concentrations of apocynin, after which aggreyalion was induced 
by addilion of 1 S mM arachidonic acid. The aggrcgatory responses 
were recorded on a dual channel pen recorder (BBC Goen Servogor 
220). 
2.5. Materids 
Apocynin was oblained from Carl Rolh GmbH, Karlsruhe, Gcr- 
many. Apocynin solution was prepared freshly every day by dissolving 
it in a minimal volume of ethanol, and subsequently diluting it in 
Krebs-bicarbonate solution. The final ethanol concentration did not 
exceed 0.1%. A specific xdioimmunoassay for TxB2 was obtained 
from NEN du Pant de Nemours, Den Bosch, The Netherlands (NEK- 
007). Arachidonic acid was purchased from Sigma Chemical Co., St. 
Louis, MO, as a free acid and wus stored at -20°C in hexane. Prior 
to each experiment. he arachidonatc salt was prepared by cvapora- 
tion of hexunc with nitrogen and addition of an equal volume of0.5 
M KOH in ethanol. After evaporation of the ethanol with nitrogen. 
the salt was dissolved in Krebs-bicarbonate solution. PMA was also 
oblained from Sigma. 
The results were statistically evaluated using Student’s f-test. Diffcr- 
enccs were considered significant at fQO.05. 
3. RESULTS 
Incubation of guinea pig PM with increasing concen- 
trations of apocyni 2 reveaied that the production of 
HHT was dose-dependently inhibited (Fig. 1). At 3 125 
~@~l (==20 mM) almost total inhibition of HHT pro- 
reo 1 
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Fig. 1. Effect of apocynin on the production of I?-hydroxy-hcpladeca- 
tricnoic acid (HHT, open bars) and thromboxanc BI (TnB:. hatched 
bars) by guinea pig pulmonary macrophages. HHT was measured by 
reverse phase HPLC and TxB, was measured by spLvrific radioimmu- 
noassay, as described in Materials and Methods, The data represent 
the mean k SEM of 7 and 4 separate cxpcriments, respectively. Bass: 
HHT production was 1.5WO.51 ~~5x10” cells, and basal TxB2 pro- 
duction amounted to 0.75kO.04 ,ugISxlOh cells. ‘PeO.05. “PcO.005. 
“‘PC0 0005. 
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Fig. 2. Effect of apocynin on the production of prostaglandin E2 
(PGE:. hat&d bars) and prostaglandin F, (PGFa. open bars) by 
guinea pig pulmonary macrophages. PGE2 and PGF?, wcrc measured 
by reverse phase HPLC, as &scribed in Materials and Methods. The 
data arc an example from one experiment. and are expressed as milli- 
absorbance units (mAU). One mAU corresponds to approximately 
I20 ng of the respective prostaglandins. 
duction was achieved. A similar pattern was observed 
when the formation of TxBl was measured (see Fig. 1). 
At the highest concentration used, apocynin signif- 
cantly inhibited TxB2 formation, whereas it was not 
inhibitory at the lower concentrations. At 25 pg/ml it 
even stimulated TxB2 formation slightly. The formation 
of TxB2 directly reflects TxA2 generation, since TxB, is 
the biologically inactive breakdown product of TX& a 
substance which induces e.g. aggregation of platelets 
[I I-131. HHT formation is also considered to closely 
parallel TxAl productisr! [14, IS]. 
In contrast o the inhibitory effect towards HHT and 
TxB,, apocynin stimulated the formation of PGE? and 
PGF?, (Fig. 2). In the absence of apocynin, about 300 
ng PGE,/5xIO” cells were formed, whereas PGF, for- 
mation was 590 ng/5x106 cells. Increasing concentra- 
tions of apocynin remarkably increased the generation 
0’ ---j 
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Fig. 3. Effect of apocynin on ardchidonic acid-induced aaregation of 
bovine platclcts. The data are expressed as the mcan+SEM of S-9 
separate cxpcriments. ‘PcO.05. “‘fQO.0005. 
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of PGE, and PGF?,. The formation of other prosta- 
glandins was not detectable, 
In order to investigate whether the inhibitory activity 
of apocynin towards HHT and TxB? is also reflected in 
thromboxane-dependent cellular responses, we deter- 
mined the effects of apocynin on arachidonic acid-in- 
duced platelet aggregation. Platelet aggregation in- 
duced by arachidonic acid is largely dependent on the 
conversion to TxA, [la]. The concentration range of 
apocynin used in this series of experiments was between 
0.5 and 15 pg/ml(=4-lOOpM), much lower than in the 
metabolic studies. It can be seen from Fig. 3 that 
apocynin inhibited arachidsnic acid-lpd:rced aggrega- 
tion of bovine platelets in a concentr,,:icn-dependent 
fashion. The estimated ICso was about 15 yM. As a 
control, the cyclooxygenase inhibitor indomethacin (I
PM) totally inhibited platelet aggregation (results not 
shown). 
4. DISCUSSION 
Our present results indicate that apocynin may be 
involved in the anti-inflammatory properties of root 
extracts of P. kiirroa not only via an effect on oxygen 
radical production by inflammatory cells [4], but also 
via an effect on the generation of arachidonic acid- 
derived inflammatory mediators. Thus, apocynin inhib- 
ited the formation of the pro-inflammatory compound 
TxA,, whilst it enhanced the formation of the anti-in- 
flammatory PGE?. This opposite effect on TxA? and 
PGE? suggests that apocynin does not affect the cy- 
clooxygenase nzyme, but may rather inhibit throm- 
boxane synthetase. When TxA, synthesis would be in- 
hibited by apocynin, one would expect accumulation of 
the PGM? intermediate to result in increased formation 
of other prostaglandins, including PGE: and PGFI, as 
observed in our experiments. The inhibitory activity of 
apocynin towards TxAL, formation in PM was not par- 
ticularly potent, considering that total inhibition was 
only achieved at 3125 ,~g/ml (=20 mM). Many other 
drugs have been shown to inhibit thromboxane synthe- 
tase with I&, values of lo-” M to IO-” M [16]. How- 
ever, our functional studies with bovine platelets dem- 
onstrate that apocynin may actually be effective at mi- 
cromolar conwntrations when looking at plate!ct aggre- 
gatory reponses. The difference in potency between in- 
hibition of HHT/TxB,! formation and inhibition of 
platelet aggregation can be explained in several ways. 
It is conceivable that the kinetics of apocynin action 
towards guinea pig PM are diffeicnt from those of the 
drug towards bovine platelets, e.g. the uptake of the 
drug may be different in the two cell types. Also, it is 
possible that apocynin is degraded by reactive oxygen 
species produceJ by the stimulated PM. This is sup- 
ported by the observation that apocynin is a scavenger 
of HzOz (unpublished observation). 
The effect of apocynin on the release of reactive oxy- 
gen species by neutrophils has been reported to be de- 
pendent on metabolic activation of the drug by reactive 
oxygen species formed through myeloperoxidase activ- 
ity [4], Since PM do not contain myelopcroxidase, we 
can conclude that apocynin either(i) directly affects the 
generation of arachidonic acid-derived mediators in 
PM, or (ii) is metabolically activated by reactive oxygen 
species which are not formed through myeloperoxidase 
activity. Future research will be needed to clarify this 
point. 
The present results with apocynin suggest that, beside 
its therapeutic effects in inflammatory conditions [3] 
and possibly in asthmatic diseases [2], the drug may also 
be a valuable tool in the development of new anti-in- 
flammatory or anti-thrombic drugs. 
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